期刊文献+

PI3K p55γ调节亚单位N末端24个氨基酸抑制胃癌细胞增殖 被引量:3

The N-terminal 24 amino acids of the p55 gamma regulatory subunit of phosphoinositide 3-kinase inhibit the proliferation of gastric carcinoma cells
在线阅读 下载PDF
导出
摘要 目的 p55γ是磷脂酰肌醇3 激酶(PI3K)的调节亚单位之一,在调节PI3K活性上具有重要的作用,本研究旨在观察p55γN末端24个氨基酸对胃癌细胞增殖的影响。方法 用脂质体介导将表达质粒pEGFPC1和pEGFPC24转染MGC 803细胞,通过荧光显微镜鉴定转染基因的蛋白表达;MTT法观察转染细胞的生长情况;软琼脂集落形成实验确定单个细胞的增殖力;最后用流式细胞仪分析细胞周期时相的变化。结果 (1)建立了稳定表达GFP和GFP N24的MGC 803细胞系,分别命名为C1/803和C24/803。(2)与对照组C1/803相比,C24/803细胞生长速度减慢,其在软琼脂中集落形成率下降了86.8%。(3)C1/803和C24/803细胞周期G0 /G1期百分率分别为52.5%和59.5%,两者相比差异有显著性(P<0.05)。结论 p55γN末端24个氨基酸能够抑制胃癌细胞的生长和增殖,引起细胞周期G1 /S期延长,提示N24p55γ可能成为治疗胃癌的潜在的分子药物。 Objective p55 gamma is one of the regulatory subunits of phosphoinositide-3 kinase(PI3K), which plays an important role in regulation of PI3K activity. This study was designed to elucidate the effects of the N-terminal 24 amino acids of p55 gamma on the growth and proliferation of gastric carcinoma. Methods Using the plasmids of pEGFPC1and pEGFPC24 to transfect MGC-803 cell line by Lipofectamine. The expression of transfected genes were identified by fluorescence microscope; the curve of cells growth was determined by MTT assay; the ability of proliferation of MGC-803 cells was measured by the rate of cloning formation; cell cycle of MGC-803 cells was assayed by flow cytometry. Results Transfected MGC-803 cell lines were established, which can stably expressed GFP and GFP-N24. We designated them as C1/803and C24/803 respectively. ②Compared with the control cells C1/803, the growth rate of C24/803 was decreased. The rate of cloning formation in soft agar of C24/803 descended 86.8%. ③The percentage of C1/803 and C24/803 cells in G 0/G 1 phase were 52.5% and 59.5%, respectively. There was significant difference between them ( P < 0.05). Conclusion The results demonstrated that the N-terminal 24 amino acids of the p55(N24 p55) gamma inhibit the growth and proliferation of gastric carcinoma through arresting the cell cycle at G1/S checkpoint. It suggests that N24p55 gamma may be potential molecular drugs for the treatment of gastric carcinoma.
出处 《肿瘤》 CAS CSCD 北大核心 2005年第1期24-27,共4页 Tumor
基金 国家自然科学基金资助项目(编号: 30171089)
关键词 胃肿瘤 PI3K p55γ 转染 MGC-803细胞 细胞周期 细胞增殖 Stomach neoplasms Phosphoinositide-3 kinase P55 gamma Transfection MGC-803 cells Cell cycle Cell proliferation
  • 相关文献

参考文献10

  • 1Katso R, Okkenhaug K, Ahmadi K, et al. Cellular function of phosphoinositide 3-kinases: implications for development,homeostasis, and cancer [J]. Annu Rev Cell Dev Biol, 2001,17: 615-675.
  • 2Cantley LC. The phosphoinositide 3-kinase pathway [J].Science, 2002,296 (5573): 1655-1657.
  • 3Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinaseAkt pathway in human cancer [J]. Nature Reviews, 2002,2(7): 489-501.
  • 4Pons S, Asano T, Glasheen E, et al. The structure and function of p55PIK reveal a new regulatory subunit for phosphatidylinositol 3-kinase [J]. Mol Cell Biol, 1995,15 (8): 4453-4465.
  • 5Xia X, Cheng A, Akinmade D, et al. The N-terminal 24amino acids of the p55 gamma regulatory subunit of phosphoinositide 3-kinase binds Rb and induces cell cycle arrest [J]. Mol cell Biol, 2003, 23 (5): 1717-1725.
  • 6Chang F, Lee JT, Navolanic PM, et al. Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy [J]. Leukemia, 2003,17(3): 590-603.
  • 7Xia X, Serrero G. Multiple forms of p55PIK, a regulatory subunit of phosphoinositide 3-kinase, are generated by alternative initiation of translation [J]. Biochem J, 1999,341 (Pt3) : 831-837.
  • 8Inukal K, Funakl M, Nawano M, et al. The N-terminal 34residues of the 55 kDa regulatory subunits of phosphoinositide 3-kinase interact with tubulin [J]. Biochem J, 2000,346 (Pt 2): 483-489.
  • 9Decary S, Decesse JT, Ogryzko V, et al. The retinoblastoma protein binds the promoter of the survival gene bcl-2 and regulates its transcription in epithelial cells through transcription factor AP-2 [J]. Mol Cell Biol,2002, 22 (22): 7877-7888.
  • 10Ward SG, Finan P. Isoform-specific phosphoinositide 3-kinase inhibiters as therapeutic agents [J]. Curr Opin in Pharmacol, 2003, 3 (4): 426-434.?A

同被引文献58

引证文献3

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部